Key Takeaways
- • Michael Allwin joins William Blair as managing director and head of biopharma investment banking, relocating from Truist Securities where he held the same title, to lead global advisory efforts across public and private biopharma companies.
- • Allwin brings nearly 15 years of biopharma sector experience spanning M&A, equity issuances, IPOs, debt securities, PIPEs, and venture capital funding, with prior roles at Credit Suisse, RBC Capital Markets, and Deutsche Bank.
- • The hire represents William Blair's continued senior-level expansion in 2026, following recent additions of bankers in energy (Jayant Dey), chemicals (Alain Harfouche), FinTech (Rishi Sethi in London), and the acquisition of Inner Circle Sports.
- • Allwin will report to Steve Tole, managing director and head of healthcare investment banking at William Blair, positioning the biopharma practice within the firm's broader healthcare banking vertical.
Summary
William Blair has strengthened its biopharma investment banking capabilities with the appointment of Michael Allwin as managing director and head of biopharma investment banking, based in New York. Allwin transitions from Truist Securities, where he held an identical leadership role, bringing deep sector expertise and an established client network to the global investment bank.
In his new position, Allwin will oversee William Blair's comprehensive advisory platform serving public and private biopharma companies across all development stages, alongside financial sponsors and venture capital firms active in the sector. His mandate encompasses the full spectrum of capital markets and M&A services, reflecting the breadth of transactions required in a dynamic biopharma environment.
Allwin's career spans nearly 15 years in biopharma investment banking, with substantial prior experience at tier-one institutions including Credit Suisse, RBC Capital Markets, and Deutsche Bank. His transaction expertise covers M&A, equity and equity-linked offerings, IPOs, follow-on public offerings, private placements, debt securities, PIPEs, and venture capital funding—a portfolio well-suited to serving biopharma clients navigating multiple financing pathways. He holds a B.A. in political science and economics from Bucknell University.
The appointment reflects William Blair's strategic focus on sector specialization and senior leadership depth. Allwin's hire follows a series of 2026 senior banker additions across complementary sectors, including Jayant Dey in energy, Alain Harfouche in chemicals, and Rishi Sethi in FinTech (London office). The firm also acquired Inner Circle Sports during this expansion period, signaling an aggressive growth posture. Allwin will operate within the healthcare investment banking vertical under Steve Tole, managing director and head of healthcare at William Blair.
In his new position, Allwin will oversee William Blair's comprehensive advisory platform serving public and private biopharma companies across all development stages, alongside financial sponsors and venture capital firms active in the sector. His mandate encompasses the full spectrum of capital markets and M&A services, reflecting the breadth of transactions required in a dynamic biopharma environment.
Allwin's career spans nearly 15 years in biopharma investment banking, with substantial prior experience at tier-one institutions including Credit Suisse, RBC Capital Markets, and Deutsche Bank. His transaction expertise covers M&A, equity and equity-linked offerings, IPOs, follow-on public offerings, private placements, debt securities, PIPEs, and venture capital funding—a portfolio well-suited to serving biopharma clients navigating multiple financing pathways. He holds a B.A. in political science and economics from Bucknell University.
The appointment reflects William Blair's strategic focus on sector specialization and senior leadership depth. Allwin's hire follows a series of 2026 senior banker additions across complementary sectors, including Jayant Dey in energy, Alain Harfouche in chemicals, and Rishi Sethi in FinTech (London office). The firm also acquired Inner Circle Sports during this expansion period, signaling an aggressive growth posture. Allwin will operate within the healthcare investment banking vertical under Steve Tole, managing director and head of healthcare at William Blair.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.